CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

UBS Adjusts Price Target on Viatris to $26 From $23, Keeps Buy Rating

Positive
AI Analysis

Summary

UBS raised its price target on Viatris from $23 to $26 while maintaining a Buy rating on the stock.

Importance:2/10
Sentiment:
0.30
price_target_adjustmentanalyst_ratingbuy_rating
Related Companies

Read the original article

Published by yahoo_finance on October 5, 2026 1:07 PM

Read Original